Related Experiment Video
Updated: Jul 25, 2026

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
Published on: May 21, 2017
Predicting Outcomes in Trauma Patients With Cirrhosis Using Model for End-Stage Liver Disease Score: A Retrospective
Vitaliy P Natkha1, Parker Southerland1, Mhd Hasan Almekdash1
1Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Liver cirrhosis did not significantly increase trauma mortality overall. However, the Model for End-stage Liver Disease (MELD) score effectively predicted increased mortality risk in trauma patients with cirrhosis.
Area of Science:
- Trauma surgery
- Hepatology
- Critical care medicine
Background:
- Liver cirrhosis is a known risk factor for increased mortality in trauma patients.
- The specific impact of cirrhosis severity on trauma outcomes requires further stratification.
Purpose of the Study:
- To investigate the association between liver cirrhosis and mortality in trauma patients.
- To stratify the impact of cirrhosis on trauma mortality using the Model for End-stage Liver Disease (MELD) score.
Main Methods:
- Retrospective analysis of trauma center data from 2014-2018.
- Matched cohort study comparing cirrhosis patients (n=182) to controls (2:1 ratio) based on age, sex, and TRISS.
- Primary outcome: mortality; Secondary outcomes: length of stay, ICU days, ventilator days.
Main Results:
- Overall mortality was not significantly different between cirrhosis and control groups (7% vs 4%, p=0.38).
- No significant differences were observed in secondary outcomes.
- A 1.9-fold increased odds of mortality was associated with each increase in MELD score category (p=0.03).
Conclusions:
- The Model for End-stage Liver Disease (MELD) score can effectively estimate the mortality risk associated with cirrhosis in trauma patients.
- Cirrhosis severity, as indicated by MELD score, is a crucial factor in predicting outcomes for trauma victims.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
05:25Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology